Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways

Int J Biochem Cell Biol. 2013 Nov;45(11):2379-91. doi: 10.1016/j.biocel.2013.08.006. Epub 2013 Aug 16.

Abstract

β-Adrenergic receptor stimulation plays an important role in cardiomyocyte stress responses, which may result in apoptosis and cardiovascular degeneration. We previously demonstrated that toxicity of the β-adrenergic agonist isoproterenol on H9c2 cardiomyoblasts depends on the stage of cell differentiation. We now investigate β-adrenergic receptor downstream signaling pathways and stress responses that explain the impact of muscle cell differentiation on hyper-β-adrenergic stimulation-induced cytotoxicity. When incubated with isoproterenol, differentiated H9c2 muscle cells have increased cytosolic calcium, cyclic-adenosine monophosphate content and oxidative stress, as well as mitochondrial depolarization, increased superoxide anion, loss of subunits from the mitochondrial respiratory chain, decreased Bcl-xL content, increased p53 and phosphorylated-p66Shc as well as activated caspase-3. Undifferentiated H9c2 cells incubated with isoproterenol showed increased Bcl-xL protein and increased superoxide dismutase 2 which may act as protective mechanisms. We conclude that the differentiation of H9c2 is associated with differential regulation of stress responses, which impact the toxicity of several agents, namely those acting through β-adrenergic receptors and resulting in mitochondrial disruption in differentiated cells only.

Keywords: 4′,6-diamidino-2-phenylindole; 5-(and 6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate; ANOVA; Apoptosis; BSA; CM H(2)DCFDA; DAPI; DHE; DL-Dithiothreitol; DMEM; DMSO; DTT; Dulbecco's-modified eagle's medium; FBS; Fetal bovine serum; H9c2 myoblasts differentiation; HBSS; Hank's Balanced Salt Solution; ISO; Isoproterenol; MAPK; Mitochondria; NAC; PMSF; PVDF; RA; ROS; SOD2; SRB; TMRM; all-trans retinoic acid; analysis of variance; bovine serum albumin; cAMP; cyclic-AMP; dihydroethidium; dimethyl sulfoxide; isoproterenol; mPTP; mitochondrial permeability transition pore; mitochondrial transmembrane electric potential; mitogen-activated protein kinases; n-acetyl-cysteine; phenylmethylsulfonyl fluoride; polyvinylidene difluouride; reactive oxygen species; sulforhodamine B; superoxide dismutase 2; tetramethylrhodamine methyl ester; ΔΨ; β-AR; β-Adrenergic signaling; β-adrenergic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Calcium / metabolism
  • Caspase 3 / metabolism
  • Cell Death / drug effects
  • Cell Differentiation / drug effects*
  • Cell Line
  • Cell Survival / drug effects
  • Cyclic AMP / metabolism
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Isoproterenol / toxicity*
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Models, Biological
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology
  • Myocytes, Cardiac / metabolism*
  • Oxidative Stress / drug effects
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Receptors, Adrenergic, beta-2 / metabolism*
  • Signal Transduction / drug effects
  • Stress, Physiological / drug effects*
  • Superoxides / metabolism
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Antioxidants
  • Receptors, Adrenergic, beta-2
  • Tumor Suppressor Protein p53
  • Superoxides
  • Cyclic AMP
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Caspase 3
  • Isoproterenol
  • Calcium